SUIC SUIC Worldwide Holdings Ltd.
Industrial Organic Chemicals · OTC · SEC CIK 1394108 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY164.1%
TTM net income YoY78.0%
TTM EPS YoY-102.6%
Revenue 3-yr CAGR-40.2%
Net income 3-yr CAGR—
Margins
Gross margin55.6%
Operating margin-45.2%
Net margin-234.4%
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-403.3%
ROIC (approx.)—
Asset turnover1.72x
Leverage & solvency
Liabilities / assets20,510.1%
Debt / equity—
Current ratio0.00x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.63x
Accruals ratio-148.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $18,482 | $0 | $150,000 | $221,000 | $379,000 |
| Cost of revenue | $7,100 | $0 | $40,000 | $82,143 | $96,000 |
| Gross profit | $11,382 | $0 | $110,000 | $138,857 | $283,000 |
| SG&A expense | $64,017 | $157,623 | $150,995 | $64,364 | $266,416 |
| Operating income | $3,008 | $5,030 | -$531,573 | -$30,507 | $16,584 |
| Pretax income | -$119,644 | -$234,211 | -$552,753 | -$2,419 | $12,024 |
| Income tax | $0 | $0 | — | — | — |
| Net income | -$119,644 | -$234,211 | -$552,753 | -$2,419 | $12,024 |
| EBITDA | $3,008 | $5,080 | -$531,523 | -$30,457 | $16,634 |
| EPS (basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS (diluted) | — | — | 0.00 | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 290.38M | 290.38M | 283.58M | 290.35M | 320.50M |
| Balance sheet | |||||
| Cash & equivalents | $8,560 | $38,495 | $7,600 | $16,072 | $29,850 |
| Receivables | — | — | $186,799 | $362,525 | $339,025 |
| Current assets | $8,560 | $38,495 | $7,600 | $408,597 | $398,875 |
| Total assets | $9,791 | $84,197 | $109,402 | $573,028 | $592,429 |
| Current liabilities | $608,755 | $578,747 | $433,741 | $344,613 | $648,596 |
| Short-term debt | $114,355 | $97,900 | $107,734 | $172,734 | $172,734 |
| Total liabilities | $887,755 | $857,747 | $712,741 | $631,613 | $648,596 |
| Shareholders' equity | -$877,964 | -$773,550 | -$603,339 | -$58,585 | -$56,167 |
| Shares outstanding | 11.40M | 11.40M | 11.40M | 11.35M | 33.50M |
| Cash flow statement | |||||
| Operating cash flow | -$46,620 | -$174,245 | -$76,942 | -$13,778 | -$168,142 |
| Investing cash flow | $0 | $0 | $30,000 | — | — |
| Financing cash flow | $16,685 | $205,140 | $38,470 | — | $172,734 |
| Depreciation & amortization | $0 | $50 | $50 | $50 | $50 |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.